European Economic AreaBiocidal Products Regulation (BPR)

EU Commission Renews Propiconazole For Biocides, Adds Limits

The European Commission has officially renewed the approval of propiconazole as an active substance for use in biocidal products, particularly for product-type 8. This decision, detailed in Commission Implementing Regulation (EU) 2023/2596, was made on November 21, 2023, following comprehensive evaluations and consultations. The decision will enter into force on 12 December 2023.

Published in July 2024. Dates, deadlines and stages may have changed since.

Dr Steven Brennan

4 min readAI-drafted, expert reviewed

Treated timber in a storage area

The European Commission has officially renewed the approval of propiconazole as an active substance for use in biocidal products, particularly for product-type 8. This decision, detailed in Commission Implementing Regulation (EU) 2023/2596, was made on November 21, 2023, following comprehensive evaluations and consultations. The decision will enter into force on 12 December 2023.

Propiconazole, a well-known substance in the biocidal products sector, has been under scrutiny due to its classification as toxic for reproduction and potential endocrine-disrupting properties. Despite these concerns, the Commission, supported by the European Chemicals Agency (ECHA), has determined that the non-renewal of propiconazole would significantly impact society, outweighing the risks posed by its use in specific applications.

The renewed approval comes with stringent conditions to ensure minimal environmental and human exposure. These include the use of personal protective equipment, containment measures during industrial application, and specific storage requirements for treated timber. Furthermore, the Commission has restricted the use of propiconazole-treated wood, prohibiting its use in furniture and play structures from July 1, 2024.

This decision follows an extensive evaluation process by the competent authority of Finland and subsequent recommendations from the ECHA. The public consultation and discussions with Member States representatives in the Standing Committee on Biocidal Products played a crucial role in this outcome.

Propiconazole is primarily needed for temporary treatment against wood-discolouring fungi and for the treatment of structural wood and joinery in specific use classes. Alternatives such as tebuconazole and boron compounds were considered but found less effective or suitable for these specific uses.

                                                                                               

Use Category

Description

Specific Applications

Wood Preservation

Propiconazole is used to protect wood from fungi that cause decay and discoloration.

Temporary treatment against wood-discolouring fungi (anti-sapstain use through industrial treatment). Industrial and professional treatment of structural wood in use classes 3 and 4 (e.g., sheds, joists, bridges, poles, decking). Industrial and professional treatment of joinery in use classes 2 and 3 (e.g., windows, doors, rooflights).

Agricultural Fungicide

As a fungicide, it is used in agriculture to protect crops from fungal diseases.

Treatment of cereals, fruits, vegetables, and ornamental plants to control a wide range of fungal pathogens.

Turf and Ornamental Plants

Used in the maintenance of turf (like golf courses) and ornamental plants.

Control of fungal diseases in turfgrass and ornamental plants in landscapes and nurseries.

Antifungal Coatings

Propiconazole can be incorporated into coatings to provide antifungal properties.

Used in coatings for various materials, including wood, to prevent fungal growth and decay.

Professional Pest Control

In certain formulations, it is used for professional pest control applications.

Control of fungi in various professional pest management scenarios, including buildings and industrial environments.

Note: The use of Propiconazole must comply with local regulations and guidelines, especially considering its classification as toxic for reproduction and potential endocrine-disrupting properties. The recent EU regulation renewal comes with specific conditions and restrictions to ensure safety and minimal environmental impact.

The Commission's decision highlights the balance between the need for effective biocidal products and the commitment to human health and environmental safety. The conditions set forth in this renewal emphasise the importance of responsible use and strict compliance with safety measures.

For stakeholders in the biocidal products sector, this renewal presents both challenges and opportunities. Companies must adapt to the stringent conditions of propiconazole use, ensuring compliance with the new regulations. In this context, Foresight's solutions offer invaluable support, helping stakeholders navigate these complex regulations and implement effective compliance strategies.

As the industry adapts to these changes, Foresight remains committed to providing expert guidance and solutions, ensuring that the transition is smooth and compliant with the latest regulatory standards.

Contact our expert team for more information and assistance in complying with these new regulations

Questions about this change

What measures are required to minimize exposure to propiconazole under the new regulations?

The new regulations require stringent measures to minimize environmental and human exposure to propiconazole. These include the use of personal protective equipment during handling, containment measures during industrial application, and specific storage requirements for treated timber. Additionally, the use of propiconazole-treated wood is prohibited in furniture and play structures from 1 July 2024.

Why did the European Commission decide to renew the approval of propiconazole despite its potential risks?

The European Commission decided to renew the approval of propiconazole despite its potential risks because the non-renewal would have had significant societal impacts. Propiconazole is crucial for temporary treatment against wood-discolouring fungi and the treatment of structural wood and joinery. Alternatives like tebuconazole and boron compounds were found less effective or suitable for these specific uses. The decision emphasizes the need for effective biocidal products while ensuring human health and environmental safety through strict compliance measures.

Dr Steven Brennan

CEO and co-founder of Foresight, and a co-opted member of ECHA's Committee for Socio-economic Analysis. He holds a PhD in chemical engineering.

More from Dr Steven Brennan

Join 3,500+ professionals staying ahead

Foresight Weekly brings the week's regulatory changes across chemicals, product safety, sustainability, ESG and EHS into one email.

Free. Unsubscribe at any time.

Read by professionals at

  • Boeing
  • AstraZeneca
  • Siemens
  • PepsiCo
  • SpaceX